Cargando…
Perampanel in lissencephaly-associated epilepsy
We retrospectively investigated whether perampanel (PER) could serve as an alternative for treating drug-resistant seizures in lissencephaly. We investigated the following data: age at onset of epilepsy, age at start of PER, etiology, brain MRI findings, seizure type, seizure frequency, adverse effe...
Autores principales: | Ikemoto, Satoru, Hamano, Shin-ichiro, Hirata, Yuko, Matsuura, Ryuki, Koichihara, Reiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351285/ https://www.ncbi.nlm.nih.gov/pubmed/30723672 http://dx.doi.org/10.1016/j.ebcr.2019.01.001 |
Ejemplares similares
-
Predictive factors of first dosage intravenous immunoglobulin-related adverse effects in children
por: Kubota, Jun, et al.
Publicado: (2020) -
Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018) -
Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017) -
Perampanel and Visuospatial Skills in Children With Epilepsy
por: Operto, Francesca Felicia, et al.
Publicado: (2021) -
Experience of Low Dose Perampanel to Add-on in Glioma Patients with Levetiracetam-uncontrollable Epilepsy
por: CHONAN, Masashi, et al.
Publicado: (2020)